Pharmaids Pharmaceuticals has informed that Saffron Capital Advisors (Manager to the Open Offer) has submitted to BSE a copy of Letter of Offer (LOF) for the attention of the Public Shareholders of Pharmaids Pharmaceuticals (Target Company).
The above information is a part of company’s filings submitted to BSE.